stella
beta
LEARNER- Low dosE AspiRiN prEterm tRial (Angola) — Stella
Home
/
Sickle Cell Disease
/
View on ClinicalTrials.gov
Recruiting
Back to Sickle Cell Disease trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
Angola
Instituto Nacional de Investigação Em Saúde, Luanda
Age range
15 Years and older
Sex
Female only
Last updated May 2024